Navigation Links
Spanish Drug Companies Have New Support Option for the U.S. Market
Date:7/19/2011

BARCELONA, Spain, July 19, 2011 /PRNewswire/ -- Spanish drug companies face a number of obstacles to commercialize products or technologies in the United States.  From regulatory (FDA) and GMP compliance, to distribution agreements and the search for project funding, there are many areas that must be coordinated.  Those issues have just become easier to manage as Spanish company KIM and U.S. company VPCI have entered into a joint association.  The collaboration will provide Spanish pharmaceutical, biotechnology and medical device companies the necessary support for compliance and commercialization of their products or know-how in the U.S. market.

(Logo: http://photos.prnewswire.com/prnh/20110719/DE35430LOGO)

"This collaboration will provide a unique set of benefits," said Franco DeVecchi, Jr., Vice President of VPCI.  "A Spanish pharmaceutical or medical device company looking to enter the U.S. market can now focus on a single point of contact for support.  Our association with KIM allows for local guidance from a project's conception all the way through commercialization in the U.S.  The services of our group have now been greatly expanded and our clients will see immediate benefits."

The agreements were signed in Washington D.C. during the BIO Washington 2011 conference in which KIM participated jointly with the Catalan delegation led by Biocat.  The convention is one of the largest in the international biotechnology sector.  KIM's Healthcare Director, Marti Dalmases said, "We are happy to expand our network of partners.  This new agreement is definitely going to help with the arrival in the U.S. of technologies developed in Spain."

About VPCI

VPCI, Inc. (Vectech Pharmaceutical Consultants International) (www.vpcint.com) is a Pharmaceutical consulting company in the U.S. which offers FDA regulatory guidance, manufacturing technology support
'/>"/>

SOURCE VPCI, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
2. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
3. Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases
4. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
5. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
6. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
7. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
8. BIOCOMs 4th Annual DeviceFest Honors Companies
9. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
10. Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum
11. Facilitation Payments Seen as Problematic by Many Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... CINCINNATI, July 7 Procter & Gamble Pharmaceuticals (P&GP) ... tablets, which are indicated for the treatment of moderately ... disease. UC involves inflammation of the lining of the ... followed by periods of remission. Moderately active UC is ...
... Tenn., July 6 /PRNewswire/ -- A Pebble Beach ... cure for multiple sclerosis. The researchers took home the top ... and the non-profit Band Against MS (BAMS) organization. The money ... at the University of Texas Health Science Center at ...
Cached Medicine Technology:Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets 2Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets 3Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets 4Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets 5Clay Walker's Band Against MS Foundation Donates $150,000 To Support Multiple Sclerosis Research 2
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... Retina, it has been found that a drug, which ... effective// in treating cystoid macular edema (CME), a common ... two patients with severe retinal swelling who were not ... Avastin, works in colorectal cancer by inhibiting the blood ...
... found that intake of foods during pregnancy plays a vital ... intake of diet// and behavior of child are interrelated, and ... less nutritious food at the time of pregnancy. ,Dr. ... study, which found that children born to iron-deficient teenage mothers ...
... Hospitals Trust has been fined ?100,000 after pleading guilty ... 31 following a routine operation//. The trust has pleaded ... ,Sitting at Winchester Crown Court, Mr Justice ... costs following the health and safety prosecution prompted by ...
... of the NHS, Sir Ian Carruthers, has proposed cost cutting ... ,He proposes to unveil his plan at a No ... believes the ?10.3 billion spent every year on drugs and ... Fears that patients would not be given expensive treatments from ...
... the William Harvey Research Institute has ... dark chocolate on heart patients//. He ... trial once he gets the regulatory ... with cardiovascular disease will be tested ...
... & Lomb Inc's brand cleansing solution has been linked to ... cause blindness//. Optometry doctors in the U.S have urged contact ... , Bausch & Lomb Inc. has ... since Monday following warnings from the U.S. Food and Drug ...
Cached Medicine News:Health News:Hospital Trust Fined ?100,000 after Patient Deat 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: